| P50 | author | Daniel J. Sargent | Q43055483 |
| P2093 | author name string | Richard M Goldberg | |
| | Michael J O'Connell | |
| | Jan C Buckner | |
| | Shauna L Hillman | |
| | Ming-Wen An | |
| | Paul Schaefer | |
| P2860 | cites work | A theoretical approach to choosing the minimum number of multiple tumors required for assessing treatment response | Q81339685 |
| | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| | CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure. | Q36428874 |
| | Response evaluation: beyond RECIST. | Q36882013 |
| | End points and United States Food and Drug Administration approval of oncology drugs | Q39396543 |
| | Randomized phase II study of two irinotecan schedules for patients with metastatic breast cancer refractory to an anthracycline, a taxane, or both | Q44978589 |
| | Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer | Q46982023 |
| | Variability in response assessment in solid tumors: effect of number of lesions chosen for measurement. | Q47446816 |
| | Factors Affecting Workload of Cancer Clinical Trials: Results of a Multicenter Study of the National Cancer Institute of Canada Clinical Trials Group | Q59647336 |
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3205-3210 | |
| P577 | publication date | 2009-05-04 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Evaluation of the optimal number of lesions needed for tumor evaluation using the response evaluation criteria in solid tumors: a north central cancer treatment group investigation | |
| P478 | volume | 27 | |